In addition, the systemic coagulation and bleeding may ... patient with fresh frozen plasma and monitoring the PT and PTT can exclude liver disease. The values will normalize somewhat, then ...

Belief BioMed (BBM) and Takeda China have announced the receipt of China’s NMPA approval for BBM-H901for treating haemophilia ...

Belief BioMed and Takeda China today jointly announced that BBM-H901, has been officially approved by the National Medical ...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the appointment of Thomas ...

Information was gathered from electronically stored patient records ... 45% of cases had a co-existing diagnosis of liver cirrhosis (n=9), 35% chronic renal failure, 25% (n=7) had diabetes (n=5), 20% ...

Patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are at high risk of bleeding with traditional artificial liver support systems.

U.S. researchers are about to test if livers from gene-edited pigs could treat people with sudden liver failure — not with a ...

Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its ...

Increasing evidence highlights a bidirectional relationship between circadian disruption and hepatic pathophysiology, suggesting liver disease is both a consequence and a driver of circadian ...